rss
Heart 2009;95:870-876 doi:10.1136/hrt.2008.155853
  • Global burden of cardiovascular disease

Coronary artery disease in Brazil: contemporary management and future perspectives

  1. C A Polanczyk,
  2. J P Ribeiro
  1. Cardiology Division, Hospital de Clínicas de Porto Alegre and Department of Medicine, Faculty of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
  1. Professor C A Polanczyk, Cardiology Division, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos 2350, sala 2060, 90035-007 Porto Alegre, RS, Brazil; cpolanczyk{at}hcpa.ufrgs.br
  • Accepted 24 November 2008
  • Published Online First 3 March 2009

Abstract

Cardiovascular diseases are responsible for 32% of total mortality in Brazil, mostly due to cerebrovascular and coronary artery disease. Epidemiological and socio-economical factors play a pivotal role on the distribution, severity and management of coronary artery disease, and the burden is greater in the southeast and south regions of the country, with a higher mortality in low-income populations. The Brazilian healthcare structure is divided into two complementary systems—public and private—but 75% of the population is covered exclusively by the public system. Some Brazilian institutions offer state-of-the-art care to patients with acute and chronic coronary artery disease, but regional inequalities in medical care are still significant. National policies will have to be implemented to fight risk factors, to ensure primary prevention strategies, including assistance on drugs with known protective effects, areas to be tackled by both the private and the public health sectors. Finally, large investments will have to be made to improve tertiary care, to reorganise systems of care for acute patients and mainly to ensure prompt access and continuity of cardiac care and secondary prevention strategies for the whole population.

Footnotes

  • Funding: CAP and JPR receive research sponsorship from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Brazil.

  • Competing interests: CAP is a consultant for the Brazilian Ministry of Health and has received research grants from Boehringer Ingelheimer and Sanofi Aventis. JPR has received consulting and lecturing fees as well as grant support from the following companies: Abbott, Bayer, Boehringer Ingelheimer, Bristol-Myers-Squibb, Cordis, Sanofi-Aventis and Servier.

This Article

  1. All Versions of this Article:
    1. hrt.2008.155853v1
    2. 95/11/870 most recent

Services

  1. Request permissions

Responses

  1. Submit a response
  2. No responses published

Social bookmarking

Latest from Education in Heart

Latest from Education in Heart

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Heart.
View free sample issue >>

Free archive
The full back archive is now available for Heart. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.